Fonte: Frontiers in endocrinology. Unidade: FM
Assuntos: DIABETES MELLITUS, COVID-19, TELEMEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSTA, Laszlo et al. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. Frontiers in endocrinology, v. 14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54572. Acesso em: 09 ago. 2024.APA
Rosta, L., Menyhart, A., Mahmeed, W. A., Al-rasadi, K., Al-alawi, K., Banach, M., et al. (2023). Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. Frontiers in endocrinology, 14. doi:10.3389/fendo.2023.1129793NLM
Rosta L, Menyhart A, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Lotufo PA, Santos Filho RD dos. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement [Internet]. Frontiers in endocrinology. 2023 ; 14[citado 2024 ago. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54572Vancouver
Rosta L, Menyhart A, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Lotufo PA, Santos Filho RD dos. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement [Internet]. Frontiers in endocrinology. 2023 ; 14[citado 2024 ago. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54572
